The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Mechanisms of resistance to bispecific T-cell engager therapy for ovarian cancer.
 
Syem Barakzai
No Relationships to Disclose
 
Mengyao Xu
No Relationships to Disclose
 
Irva Veillard
No Relationships to Disclose
 
Yusuke Matoba
No Relationships to Disclose
 
Artem Kononenko
No Relationships to Disclose
 
Eugene Kim
No Relationships to Disclose
 
Amy Bregar
No Relationships to Disclose
 
Eric L Eisenhauer
No Relationships to Disclose
 
Richard T. Penson
Honoraria - AstraZeneca; Genentech/Roche; GlaxoSmithKline; Immunogen; Merck; Mersana; Novocure; Sutro Biopharma; Vascular Biogenics
Consulting or Advisory Role - AstraZeneca; Care4ward; Genentech; GlaxoSmithKline; Immunogen; Merck; Mersana; Novocure; Sutro Biopharma; Vascular Biogenics
Research Funding - Array BioPharma (Inst); AstraZeneca (Inst); Cerulean Pharma (Inst); Eisai (Inst); Genentech (Inst); Regeneron (Inst); Sanofi (Inst); Tesaro (Inst); Vascular Biogenics (Inst)
Patents, Royalties, Other Intellectual Property - Blackwell Publishing; BMJ; UpToDate
Other Relationship - AstraZeneca; Roche
 
Sara Bouberhan
Consulting or Advisory Role - Immunogen
 
Tina Colella
No Relationships to Disclose
 
Caroline Clark
No Relationships to Disclose
 
Cesar Martin Castro
Consulting or Advisory Role - Advanced Medical; InfiniteMD; Qiagen
Patents, Royalties, Other Intellectual Property - Co-inventor: Holographic diagnostic profiling; Co-inventor: Nanoplasmonic exosome profiling
 
David R. Spriggs
Leadership - Repertoire Immune Medicines
Consulting or Advisory Role - Brahma Therapeutics; Repertoire Immune Medicines
Speakers' Bureau - Brahma Therapeutics
Patents, Royalties, Other Intellectual Property - Through my laboratory, we haver discovered anti-MUC16 antibodies that MSKCC has filed patents about. These patents, if commercialized could ultimately result in royalties paid to me. (Inst)
 
Bo R Rueda
Research Funding - Novartis (Inst); Palleon Pharmaceuticals (Inst)
 
Oladapo O. Yeku
Stock and Other Ownership Interests - hC Bioscience
Honoraria - Medscape
Consulting or Advisory Role - Gimv; hC Bioscience; TigaTx
Patents, Royalties, Other Intellectual Property - Dr. Yeku has a patent for MUC16 Directed Antibodies for therapeutic applications pending and a patent for Human Artificial Chromosomes for therapeutic applications pending.